Publications by authors named "M Spahn"

Claim this Profile
C
Comparative evaluation of radiolabeled bombesin analogs [Lu]Lu-AMBA and [Lu]Lu-RM2 for targeting GRPR in glioblastoma model.
Michal Grzmil, Muriel Aline Spahn, Philipp Berger, Roger Schibli, Martin Béhé

Nucl Med Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional Cohort.
Alexander Giesen, Daimantas Milonas, Annouschka Laenen, Lorenzo Tosco, Piotr Chlosta, Martin Spahn

Eur Urol Open Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
xCT as a potential marker for neuroendocrine cells in high-risk prostate cancer and the relation to AL122023.1-miR-26a/30d/30e axis.
Elena D Wilhelm, Jaroslaw T Dankert, Marc Wiesehöfer, Sven Wach, Mathias Wagner, Martin Spahn

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective PET imaging of CXCR4 using the AlF-labeled antagonist LY2510924.
Muriel Aline Spahn, Tom Van Loy, Sofie Celen, Michel Koole, Christophe M Deroose

Eur J Nucl Med Mol Imaging· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indium-111-Labeled Single-Domain Antibody for CXCR4 Imaging Using Single-Photon Emission Computed Tomography.
Muriel Aline Spahn, Stephanie Mareike Anbuhl, Kaat Luyten, Tom Van Loy, Matti F Pronker

Bioconjug Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis